Staphylococcus aureus bacteremia: relationship between formation of antibodies to teichoic acid and development of metastatic abscesses

A comparative analysis of antibody repertoire against Staphylococcus aureus antigens in patients with deep-seated versus superficial staphylococcal infections

Immunoblot and an enzyme-linked immunosorbent assays were used to evaluate and compare IgG antibodies against S. aureus whole cell lysate, cell wall peptidoglycan and lipoteichoic acid to discriminate between deep-seated and superficial S. aureus infection. Serum samples were examined from patients with deep-seated (n = 25) and superficial (n = 25) S. aureus infections and 15 healthy controls. Patients with deep-seated infections exhibited a large number of immuno-reactive bands in their IgG immunoblot profile as compared to those with superficial infections and healthy controls. Anti-staphylococcal IgG antibodies that reacted with two antigens of apparent molecular weight 110 and 98 kDa were specifically present in 96% (24/25) of patients with deep-seated infections, and were absent in, superficial and control sera. Moreover other Gram-positive and Gram-negative bacteria did not share these two unique antigens. The ELISA assays revealed significantly elevated levels of IgG antibodies to peptidoglycan (PG) in 18 of 25 (72%) patients with deep infection and 15 of 25 (60%) patients with superficial staphylococcal infection. The elevated levels of IgG antibodies to teichoic acid (TA) antigen were detected in all (100%) deep-seated group patients and among 40% (10/25) patients with superficial infection. An increase in levels of antibodies to PG showed a positive correlation trend with levels of IgG antibodies to TA only in deep infection group. Thus immunoblot detection of these two unique antigens as well as detection of elevated antibodies against PG and TA may be useful for the discrimination of staphylococcal deep-seated and superficial infection in humans.

IgG antibody response in bacterial endocarditis using ELISA with multiple antigens

By means of enzyme-linked immunosorbent assays (ELISAs) the antibody responses were detected in sera from normal persons (n = 275), patients with various types of bacteremia (n = 137), and patients with endocarditis (n = 28). Four ELISAs were evaluated. As antigens ultrasonic extracts of Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, and nonhemolytic streptococci were used. The antibody levels against S. aureus increased with age, while antibodies against the other bacteria showed no age variation. The different ELISA systems showed many serological cross-reactions. The ELISA in this limited material was 72% successful in identifying cases of bacterial endocarditis caused by S. aureus (diagnostic sensitivity 84%; diagnostic specificity 89%), while in other cases of bacterial endocarditis it was less successful.

Crossed immunoelectrophoresis used for bacteriological diagnosis in patients with endocarditis

Sera from 151 patients suspected of having endocarditis were obtained during a period of 3 1/2 years at Rigshospitalet, Copenhagen. The sera were examined by crossed immunoelectrophoresis for antibodies to bacteria causing endocarditis. The patients were divided into four groups: 1. Patients with definite endocarditis, 2. Patients with culture-negative endocarditis, 3. Patients with uncertain endocarditis, and 4. Patients without endocarditis. In sera from patients suffering from endocarditis caused by viridans streptococci, precipitating antibodies were demonstrated by crossed immunoelectrophoresis (diagnostic specificity = 86%; diagnostic sensitivity = 100%) while other bacterial etiologies of endocarditis were less reliably demonstrated by this method.

Preparation of a latex reagent for the detection of anti-Staphylococcus aureus ribitol teichoic acid antibodies

Purified S. aureus ribitol teichoic acid was covalently bound to carboxylated latex particles. The immunological properties of the polysaccharide antigen were preserved. The reagent obtained was used for the quantification of anti-ribitol teichoic acid antibodies by means of a direct and rapid agglutination test carried out on a slide. There was good correlation between the preliminary results of this test and those obtained with counter-immunoelectrophoresis (CIE). The method is faster and more sensitive than CIE.

Antibody response to whole cells and teichoic acid of Staphylococcus aureus strain E 1369 in human sera

A whole cell Staphylococcus aureus enzyme-linked immunosorbent assay (ELISA) using the protein A-deficient strain E 1369 as antigen was compared to an ELISA with cell-wall teichoic acid, extracted from the same strain, as antigen for the detection of IgG antibodies against S. aureus in human sera. A total of 178 serum samples from 119 patients with S. aureus endocarditis, complicated and uncomplicated septicaemia, non-S. aureus endocarditis and septicaemia were investigated together with sera from 155 healthy controls. The sensitivity in diagnosing S. aureus endocarditis was better for the whole cell-ELISA (83%) as compared to the teichoic acid-ELISA (61%), and the same was true for complicated septicaemia (41% vs 29%). The whole cell ELISA was also more specific for S. aureus infections with only 3.6% false positive test values compared to 7.1% for the teichoic acid-ELISA. The differences were however, not statistically significant. None of the assays were able to distinguish between complicated and uncomplicated S. aureus septicaemia.

Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis

An enzyme-linked immunosorbent assay was used to evaluate the immunoglobulin G (IgG) response to Staphylococcus aureus crude teichoic acid (TA) and peptidoglycan (PG) in both rabbits and patients with osteomyelitis. In rabbits with experimental S. aureus osteomyelitis, elevated levels of IgG to TA were present in 13/18 (72%) of the serum samples obtained at 4 and 10 weeks postinfection. In contrast, only 5/18 (28%) of these sera were found to be positive for antibodies to PG. Of a total of 39 patients with confirmed S. aureus osteomyelitis (11 acute, 28 chronic), IgG to TA was elevated in 17 (44%), whereas antibodies to PG were found to be increased in only 1 (3%). Cross-reacting antibodies to S. aureus TA were detected in only 1/18 (6%) of the patients with osteomyelitis caused by organisms other than S. aureus. These studies indicate that IgG to TA is more prevalent than IgG to PG in patients with staphylococcal osteomyelitis. Although these results are encouraging, a larger number of patients is required for an adequate evaluation of the TA enzyme-linked immunosorbent assay for the diagnosis and management of suspected S. aureus osteomyelitis.

Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia

A randomized cooperative study of therapy for Staphylococcus aureus bacteremia was conducted in which nafcillin was given for four or six weeks to patients with clinical endocarditis and for two or four weeks to those without evidence of endocarditis. Eighty-four patients were enrolled, and 32 completed treatment, all of whom had bacteriologic cures. Three patients, treated for two weeks, had complications that were undetectable by assay of serum teichoic acid antibody. Data were insufficient to allow conclusions regarding the optimal duration of therapy for patients with or without endocarditis. However, the results suggest that neither clinical nor immunologic methods can reliably detect complications in patients treated for two weeks only. In addition, patients infected with tolerant organisms remained febrile longer than those infected with nontolerant strains but did not require additional antibiotics for cure. Peak serum bactericidal activity at a dilution of 1:8 or greater was present in all patients. Serum bactericidal activity of 1:8 prior to an antibiotic dose was not necessary for cure.

Antibody response against whole Staphylococcus aureus in patients with staphylococcal septicaemia and endocarditis investigated by ELISA

A whole cell Staphylococcus aureus enzyme-linked immunosorbent assay (ELISA) for the detection of IgG antibodies against S. aureus has been developed. To avoid non-specific binding of IgG to protein A, the protein A-poor strains of S. aureus, E 1369 and Wood 46, were used as antigens. One-hundred and eighty serum samples from 120 patients with S. aureus endocarditis, non S. aureus endocarditis, S. aureus septicaemia and non S. aureus septicaemia were tested together with sera from 155 healthy controls. The sensitivity was similar for the E 1369 ELISA and the Wood 46 ELISA and positive test values were detected in 84.2% of patients with S. aureus endocarditis and 41.2% of patients with complicated S. aureus septicaemia. No distinction could be found between complicated and uncomplicated S. aureus septicaemia. The E 1369 ELISA was more specific showing cross reactions with sera from patients infected with other bacteria than S. aureus in 3.6%. Furthermore, the reproducibility was better for the E 1369 ELISA with a coefficient of variation at 0.054. The absence of need for purified antigens makes the whole S. aureus ELISA easy, rapid and cheap. Therefore, we suggest the whole S. aureus ELISA as a good alternative to previously reported assays using purified cell wall antigens.

Enzyme-linked immunosorbent assay for detection of immunoglobulin G and M antibodies to teichoic acid in intravascular staphylococcal disease

An enzyme-linked immunosorbent assay (ELISA) for detection of IgG and IgM antibodies to cell-wall teichoic acids of Staphylococcus aureus and three defined coagulase-negative staphylococci was tested using serum samples from 11 cases of intravascular coagulase-negative staphylococcal infections, 13 cases of Staphylococcus aureus endocarditis, and 24 patients with no evidence of infection. IgG antibody titers to all four teichoic acids in the 13 patients with Staphylococcus aureus endocarditis were significantly different from those in noninfected control patients (p less than 0.0001). In contrast, IgG antibody titers in serum from 11 cases of intravascular coagulase-negative staphylococcal infection were not significantly different from those in control sera. There were no differences in IgM antibody titers of the three groups. Although the ELISA was sensitive in detecting Staphylococcus aureus endocarditis, it was not reliable in the detection of intravascular coagulase-negative staphylococcal infections, even when tested with specific teichoic acid.

Serological diagnosis of Staphylococcus aureus osteomyelitis

We have evaluated serological tests for the diagnosis of Staphylococcus aureus osteomyelitis. Antiteichoic acid antibodies were elevated in 17 of 23 patients with acute and 16 of 46 with chronic S. aureus osteomyelitis but in none of 33 patients infected with other gram-positive or gram-negative bacteria. Immunoglobulin G antibodies to S. aureus were elevated in 12 of 23 patients with acute and 22 of 47 with chronic S. aureus osteomyelitis, in 2 of 12 infected with other gram-positive bacteria, and in 4 of 21 with other gram-negative bacteria. Assays for S. aureus antibodies may be useful for identifying patients with S. aureus bacteremia complicated by metastatic sites of infection in bone and for identifying the etiological agents in patients with negative or mixed cultures or from whom cultures are not readily available. Prospective studies are needed to test these hypotheses.

Comparison of anti-alpha-haemolysin and teichoic acid antibody tests in patients with Staphylococcus aureus endocarditis or bacteraemia

To assess the value of serological tests in differentiating endocarditis and complicated bacteraemia due to Staphylococcus aureus from uncomplicated S. aureus bacteraemia and from nonstaphylococcal endocarditis we measured teichoic acid antibodies (TAA) (by means of a gel diffusion method) and antibodies to alpha-haemolysin (ASta) in the serum of 22 patients with S. aureus endocarditis, 42 patients with complicated S. aureus bacteraemia, 21 patients with uncomplicated S. aureus bacteraemia, 27 patients with other than S. aureus endocarditis, 17 patients with culture-negative endocarditis and 337 non-infected control patients. TAA and ASta titres were found significantly more often in staphylococcal endocarditis than in non-staphylococcal endocarditis, 59 per cent versus 4 per cent for the TAA test and 32 per cent versus 0 per cent for the ASta assay. The combined use of the two tests proved best for differentiating the two groups of endocarditis from each other, 72 per cent versus 4 per cent respectively. In the culture-negative endocarditis group there were two serologically positive patients whose anti-staphylococcal antibiotic therapy based on the serological findings was successful, supporting the clinical usefulness of staphylococcal serological tests in endocarditis of unknown bacterial aetiology. The serological tests were not useful, however, in differentiating S. aureus endocarditis from complicated or uncomplicated bacteraemia due to S. aureus without endocarditis.

A comparative study of osteomyelitis and purulent arthritis with special reference to aetiology and recovery

We analysed the records of 44 paediatric cases of acute haematogenous osteomyelitis (age 0-14 years) and 25 cases of purulent arthritis (age 0-13 years). The annual incidences were 4.5 and less than two per 100,000 children, respectively. Bacteriologic diagnosis was achieved in 82% of the acute haematogenous osteomyelitis cases and in 40% of the acute purulent arthritis cases. Staphylococcus aureus was responsible for 70% of the proven acute haematogenous osteomyelitis and acute purulent arthritis cases combined, followed by streptococci (20%) and Haemophilus influenzae (7%), which caused only acute purulent arthritis. Acute haematogenous osteomyelitis was localized in the femur in 41% of the cases and acute purulent arthritis in the knee joint in 76%. Surgery (in most cases drilling, fenestration or arthrotomy) was performed on 82% of the acute haematogenous osteomyelitis and on 32% of the acute purulent arthritis patients. Although six of the acute haematogenous osteomyelitis patients (but none of the acute purulent arthritis patients) underwent surgery for a second time, permanent damage, which was functionally non-significant, developed in only 14%. No sequelae were found in the acute purulent arthritis group. The average duration of antimicrobial therapy was 44 days in the acute haematogenous osteomyelitis group and 29 days in the acute purulent arthritis group. The prognosis for the children was similar, irrespective of whether the drugs used were staphylococcal penicillins, ampicillin, lincomycin or clindamycin.

Solid-phase radioimmunoassay of immunoglobulin G antibodies to Staphylococcus aureus peptidoglycan in patients with staphylococcal infections

A solid-phase radioimmunoassay (SPRIA) for determination of antibodies against S. aureus peptidoglycan was used for serological diagnosis of staphylococcal infections. Elevated IgG antibody levels were found in 21/21 patients with S. aureus endocarditis and in 10/24 patients with S. aureus septicemia. Two patients with streptococcal and one patient with pneumococcal septicemia showed elevated antibody levels as well, probably due to cross reactions between peptidoglycans of different bacterial species. In cases of chronic osteomyelitis caused by S. aureus, 12/33 patients showed elevated antibody levels while all patients with recurrent furunculosis had normal antibody levels. Anti-peptidoglycan antibodies were also found in all healthy controls (n = 160) but at lower levels. This might explain the rapid booster response of IgG antibodies found in 73 per cent of patients with S. aureus endocarditis already within 10 days after the first symptoms. The best clinical value of the assay seems to be in separating S. aureus endocarditis from uncomplicated septicemia.

Detection of anti-teichoic acid immunoglobulin G antibodies in experimental Staphylococcus epidermidis endocarditis

An enzyme-linked immunosorbent assay (ELISA) was developed for the detection of rabbit immunoglobulin G (IgG) antibodies to purified cell wall teichoic acids from the Staphylococcus aureus Lafferty strain and three strains of coagulase-negative staphylococci. Significant immunological cross-reactivity occurred only between the teichoic acid of S. aureus and one coagulase-negative preparation. The ELISA was used to determine the serum IgG response to Staphylococcus epidermidis in a rabbit model of aortic valve endocarditis. Blood samples were drawn before inoculation and then every 5 days until death or sacrifice at 32 to 35 days postinoculation. Valve vegetations were culture positive at autopsy in 16 (59%) of the 27 catheterized rabbits. Antibody titers in this culture-positive group and the culture-negative group began to rise as early as day 6. Although both groups demonstrated an antibody response, the culture-positive group attained a significantly higher titer on days 26 and 31. Antibodies also rose in a control group of rabbits without a heart catheter but which were inoculated with bacteria. Again, the antibody titer was significantly less than that for the culture-positive group. This ELISA may be useful for the diagnosis of coagulase-negative staphylococcal infections in humans.

Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections

A highly purified teichoic acid preparation was used in an enzyme-linked immunosorbent assay to measure the specific immunoglobulin G (IgG) and IgM response in staphylococcal disease. Antibody determination in a normal population, showing a difference of up to 20-fold in the mean IgG titers between the youngest children and adults, was used to establish age-correlated upper normal values. IgM antibodies were found to be of little diagnostic value since their response was often low or absent. Increased IgG titers were found in 24 of 27 (89%) patients with endocarditis, in 11 of 14 (79%) with complicated septicemia, and in 10 of 20 (50%) with uncomplicated septicemia with serum samples drawn between days 7 and 30 of disease. With paired samples, the numbers of patients with increased IgG titers were 17 of 17, 3 of 4, and 6 of 7, respectively, in the same patient groups. Increased IgG titers were less often demonstrated in patients with chronic osteomyelitis (7 of 22). The enzyme-linked immunosorbent assay for teichoic acid antibodies was found to be a sensitive and specific method for diagnosing staphylococcal endocarditis and septicemia. For optimal results, both the substantial age-correlated variation in normal titers and the importance of adequately spaced samples should be considered.

Detection of circulating free and complexed staphylococcal antigens by enzyme-linked immunosorbent assay

An enzyme-linked immunosorbent assay was developed for the detection of circulating free and complexed staphylococcal antigens in various clinical categories of staphylococcal infections. Circulating immune complexes were studied by the polyethylene glycol precipitation method. Circulating immune complexes and staphylococcal antigen (at titers of greater than or equal to 1:32) dissociated from the complexes were found in 7 of 8 patients (87.5%) with staphylococcal endocarditis and in 4 of 20 patients with staphylococcal bacteremia (20%). Although the majority of patients did not have detectable free staphylococcal antigen, it was found in three patients with staphylococcal pneumonia. We conclude that detection of complexed antigen in high titer may differentiate patients with staphylococcal endocarditis from those with other forms of staphylococcal infection or transient bacteremia.

Assay of teichoic acid antibodies and antistaphylolysin in the diagnosis of Staphylococcal osteomyelitis

Teichoic acid antibodies (TAA), measured by gel diffusion, and antistaphylolysin (ASa) values were determined in 46 osteomyelitis patients and 200 healthy controls. A positive TAA titer (greater than or equal to 4) was seen in 4/16 patients with acute hematogenous osteomyelitis caused by Staphylococcus aureus and in 7/22 patients with chronic staphylococcal osteomyelitis, while ASta was positive (greater than or equal to 2.0 IU/ml) in 9 patients in both groups all except 2 exceeding 4.0 IU/ml. No positive TAA titres or ASta values were seen in 8 patients with chronic nonstaphylococcal osteomyelitis. The rate of positive test results in 200 controls was 7% for TAA and 4% for ASta. Basing diagnosis on a positive value in either of the tests gave 21 positive results in 38 patients with staphylococcal osteomyelitis; 18 by ASta alone and 11 by TAA alone. Both tests were positive at the same time in 3 patients with acute and in 5 patients with chronic staphylococcal osteomyelitis but never in controls.

Detection of Staphylococcus aureus antibodies in patients with S. aureus infections and in normal persons, using solid phase radioimmunoassay

One hundred and thirteen patients with S. aureus infections, eight patients with non-S. aureus septicemia and 167 normal controls were investigated by solid-phase radioimmunoassay for staphylococcal antibodies. All serum samples tested had measurable antibodies, including the normal controls. The test could differentiate the patients group with S. aureus endocarditis from patients with other S. aureus septicemia, as well as from normal controls, as the endocarditis group had significantly higher antibody levels. Patients with non-bacteremic S. aureus infections, such as osteomyelitis and recurrent furunculosis, showed a wide range of antibody levels, 1/3 and 1/4 of the patients, respectively, showing high levels comparable to the endocarditis patients. Among normal controls, high antibody levels were found in 13 per cent.

Staphylococcus aureus antibodies in patients with staphylococcal septicemia. Comparisons between solid-phase radioimmunoassay and crossed immunoelectrophoresis

Antibody responses against teichoic acids and other antigens from Staphylococcus aureus in 23 patients with septicemia and 8 patients with endocarditis caused by S. aureus were investigated. Both methods used--solid-phase radioimmunoassay (SPRIA) and crossed immunoelectrophoresis (CIE)--detected significantly higher titres in the endocarditis group. The SPRIA method utilized a sonicated extract of S. aureus, strain Wood 46 for the quantitation of antibodies. In CIE precipitating anti-teichoic acid antibodies were measured. There was no absolute correlation between the two assays, indicating that the antibodies measured were directed at partly different antigens. The two tests might be complementary to each other when used in combination.

Precipitating antibodies against Staphylococcus aureus in serum from patients with staphylococcal septicaemia, investigated by means of quantitative immunoelectrophoretic methods

Crossed immunoelectrophoresis was employed in the study of precipitating antibodies against Staphylococcus aureus in sera from 46 patients with S. aureus septicaemia. The occurrence and titres of antibodies were compared to previously reported findings for normal persons. Ten infection-specific precipitins were detected. However, most of these precipitins were detected in low titres and could only be detected during convalescence. When antibodies against a single antigen were measured, titres above the normal level were found in 39.1% - 65.2% of the patients. When the total number of precipitins in each serum was compared to findings in serum from normal persons, 54.3% of the patients had a higher value. Most promising was the precipitin score, considering both the number of precipitins and their titres. This score showed an early rise and was increased above the normal level in 82.6% of the patients. The antibody response against individual S. aureus antigens varied from person to person both concerning titres and time course.

Teichoic acid antibody and circulating immune complexes in the management of Staphylococcus aureus bacteremia

Optimal antibiotic therapy for patients with Staphylococcus aureus bacteremia remains controversial. The results of two serologic tests, teichoic acid antibody and circulating immune complexes, have shown promise in detecting patients who have serious bacteremia (sustained bacteremia with endocarditis or metastatic abscess) and require longer, more intensive treatment. These tests were performed on serial samples from 38 patients with staphylococcal bacteremia prospectively categorized by severity of infection and by risk factors associated with serious disease (sustained bacteremia, valvular heart disease, absence of focus of infection, metastatic abscess). A surprisingly large group of these patients (20, or 53 percent) could not be prospectively defined as having "serious" or "benign" bacteremia. Neither test differentiated patients with serious bacteremia from those with benign bacteremia. Although it is possible that additional significant associations with risk factors might have been obtained with the teichoic acid antibody test had more patients been included, positive tests were found more frequently only in patients in whom metastatic abscesses developed. The teichoic acid antibody test was found to be a sensitive, but not specific, indicator of serious staphylococcal disease and was of value in excluding serious infection only when a negative results was supported by clinical evidence for benign disease. Other than this use, neither assay was helpful in determining optimal therapy of staphylococcal bacteremia.

Normally-occurring precipitating antibodies against Staphylococcus aureus in human serum and colostrum

Crossed immunoelectrophoresis was used to study precipitating antibodies against Staphylococcus aureus in sera from 263 normal persons and in 10 colostrum samples. A polyspecific protein-A free S. aureus antigen preparation and a corresponding rabbit antiserum constituted the reference system. All the sera contained precipitins against 6-10 S. aureus antigens. One of these was teichoic acid, and the titre of antibodies against cell wall teichoic acid varied from person to person, in contrast to other commonly occurring antibodies. The precipitin score, which expresses the number and titre of precipitins in each serum, increased with age. Colostrum contained 3 precipitins, which were not present in the corresponding maternal sera.

Serologic diagnosis of access device-related staphylococcal bacteremia

Staphylococcal bacteremia occurs frequently in patients undergoing long-term hemodialysis (dialysis patients). Although such bacteremia is frequently uncomplicated, it may be associated with endocarditis, metastatic infection or suppuration at the access site requiring excision of the access device for control of the infection (complicated bacteremia). To distinguish patients with uncomplicated bacteremia from those with complications, we measured staphylococcal teichoic acid antibodies by agar-gel diffusion and immunoglobulin G (IgG) antibodies by radioimmunoassay in 18 patients with staphylococcal bacteremia undergoing long-term hemodialysis. Although teichoic acid antibodies were not detected in five patients with uncomplicated bacteremia, they were observed in only three of 13 patients with complicated bacteremia. IgG staphylococcal antibodies were present in 10 of 13 patients with complicated bacteremia compared to none of five patients with uncomplicated bacteremia compared to none of five patients with uncomplicated bacteremia (p less than 0.05). Thus, radioimmunoassay was spuerior to agar-gel diffusion in identifying dialysis patients with complicated bacteremia. In patients with increased concentrations of IgG staphylococcal antibodies by radioimmunoassay, the diagnosis of endocarditis, metastatic infection and suppuration at the access site should be considered. Prolonged antibiotic therapy and/or operative removal of the access device may be necessary.

Association of teichoic acid antibody with metastatic sequelae of catheter-associated Staphylococcus aureus bacteremia: a failure of the two-week antibiotic treatment

A patient with Staphylococcus aureus bacteremia associated with an infected intravenous catheter was treated with oxacillin for two weeks. During that period all blood cultures were sterile, he rapidly became afebrile, and there were no signs of endocarditis or metastatic abscesses. However, serum antibodies against staphylococcal teichoic acid, initially undetectable by the agar gel immunodiffusion technic, became positive during the second week of treatment. Three weeks after discharge, the patient was readmitted to the hospital because of back pain and weakness in the lower extremities. Vertebral osteomyelitis and a spinal epidural abscess caused by Staph. aureus of the same phage type as the bacteremic isolate were demonstrated. This case illustrates the importance of careful follow-up of patients with Staph. aureus bacteremia and the potential value of serial measurement of teichoic acid antibodies in detecting clinically inapparent complications of infection.

Teichoic acid serology in staphylococcal infections of infants and children

Counterimmunoelectrophoresis and gel diffusion were utilized for the detection and titration of antibodies to staphylococcal teichoic acids in various disease states caused by coagulase-positive staphylococcus in infants and children. Serum samples were obtained on admission and serially for 2 to 12 weeks during illness. Teichoic acid antibodies were found by CIE in 12 of 21 patients (57%) with invasive CPS disease with bacteremia (Group A), in two of 17 patients (12%) with CPS infection without bacteremia (Group B), in none of 27 patients with bacteremia and/or invasive infections caused by organisms other than CPS (Group C), and in none of 24 noninfected, hospitalized patients or healthy children (Group D). Gel diffusion was useful for titrating antibodies in seropositive sera. Teichoic acid serology is a useful adjunct in the diagnosis of invasive CPS infections. The presence of these antibodies by CIE and gel diffusion may help to identify patients with endothelial or metastatic infections associated with staphylococcal bacteremia.